Tech Company Financing Transactions
JHL Biotech Funding Round
On 6/20/2014, JHL Biotech secured $35 million in Series B funding from Milestone Venture Partners, CDIB Bioscience and Kleiner Perkins Caufield & Byers.
Transaction Overview
Company Name
Announced On
6/20/2014
Transaction Type
Venture Equity
Amount
$35,000,000
Round
Series B
Investors
Proceeds Purpose
JHL will deploy the new funds toward developing its proprietary biosimilar monoclonal antibody pipeline and accelerating its filing of investigational new drug applications.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
No.18 Sec. 2 Shengyi Rd. Zhubei City Hsinchu County 3F
Taipei City, 302
Taiwan
Taipei City, 302
Taiwan
Phone
Website
Email Address
Overview
JHL Biotech, Inc. provides contract manufacturing solutions to companies developing and commercializing affordable biologic medicines in Asia. The company offers cell line cloning, process development, and manufacturing capabilities and services to emerging and established biopharmaceutical companies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
James Huang
Chief Medical Officer
Rong Chen
VP - Bus. Development
Mahalia Corrales
VP - Human Resources
Yen Hsieh
VP - Regulatory Affairs
Allen Ho
Browse more venture capital transactions:
Prev: 6/20/2014: Navitor Pharmaceuticals venture capital transaction
Next: 6/20/2014: Western Oncolytics venture capital transaction
Share this article
News on VC Transactions
We do our best to report on funding rounds that are announced publicly. All VC database entries reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs